2021 ASPEN指南:成人危重症患者的营养支持治疗

2021-11-16 美国肠外肠内营养学会 JPEN J Parenter Enteral Nutr

2021年11月,美国肠外肠内营养学会(ASPEN)发布了成人危重症患者的营养支持治疗指南。本文是对2016年重症患者营养指南的更新,主要针对5个临床问题提出指导建议。

中文标题:

2021 ASPEN指南:成人危重症患者的营养支持治疗

英文标题:

Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition

发布日期:

2021-11-16

简要介绍:

2021年11月,美国肠外肠内营养学会(ASPEN)发布了成人危重症患者的营养支持治疗指南。本文是对2016年重症患者营养指南的更新,主要针对5个临床问题提出指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ASPEN指南:成人危重症患者的营养支持治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=813821c0023153ab, title=2021 ASPEN指南:成人危重症患者的营养支持治疗, enTitle=Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition, guiderFrom=JPEN J Parenter Enteral Nutr, authorId=0, author=, summary=2021年11月,美国肠外肠内营养学会(ASPEN)发布了成人危重症患者的营养支持治疗指南。本文是对2016年重症患者营养指南的更新,主要针对5个临床问题提出指导建议。, cover=https://img.medsci.cn/2022110/1641818922664_1608702.png, journalId=0, articlesId=null, associationId=224, associationName=美国肠外肠内营养学会, associationIntro=美国肠外肠内营养学会(ASPEN)通过推荐临床营养和代谢研究和实践的发展,以改善病人的治疗。成立于1976年,是一个跨学科的组织,成员参与临床营养治疗,包括肠外与肠内营养。超过5500名会员,包括营养师、护士、药剂师、医生、科研工作者、学生和其他医疗相关人员,涉及的内容包括营养支持的临床实践、研究和教育。, copyright=0, guiderPublishedTime=Tue Nov 16 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年11月,美国肠外肠内营养学会(ASPEN)发布了成人危重症患者的营养支持治疗指南。本文是对2016年重症患者营养指南的更新,主要针对5个临床问题提出指导建议。</span></p>, tagList=[TagDto(tagId=4852, tagName=肠外营养), TagDto(tagId=58720, tagName=营养支持治疗)], categoryList=[CategoryDto(categoryId=34, categoryName=营养全科, tenant=100), CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=66, categoryName=营养科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=58720, guiderKeyword=营养支持治疗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=16862, appHits=516, showAppHits=0, pcHits=4006, showPcHits=16345, likes=3, shares=73, comments=20, approvalStatus=1, publishedTime=Mon Jan 10 20:46:16 CST 2022, publishedTimeString=2021-11-16, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Mon Jan 10 20:51:03 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Mon Oct 02 19:07:09 CST 2023, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ASPEN指南:成人危重症患者的营养支持治疗.pdf)])
2021 ASPEN指南:成人危重症患者的营养支持治疗.pdf
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1213119, encodeId=af6e12131190c, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ea1461919, createdName=yangcheng_666139, createdTime=Thu Apr 21 12:05:53 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207126, encodeId=8b26120e1266a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:42:23 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206634, encodeId=11bb120663434, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17b55467916, createdName=ms7000001906418137, createdTime=Mon Mar 28 15:27:08 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205669, encodeId=cb73120566925, content=内容好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dae4838671, createdName=1441fef2m15暂无昵称, createdTime=Thu Mar 24 20:49:03 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204484, encodeId=5fc412044842f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/15/f4a39912ff6c27452e6ae02a2e312a5f.jpg, createdBy=6d8d1870826, createdName=果果love, createdTime=Sun Mar 20 23:07:38 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-04-21 yangcheng_666139

    想看看

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1213119, encodeId=af6e12131190c, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ea1461919, createdName=yangcheng_666139, createdTime=Thu Apr 21 12:05:53 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207126, encodeId=8b26120e1266a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:42:23 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206634, encodeId=11bb120663434, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17b55467916, createdName=ms7000001906418137, createdTime=Mon Mar 28 15:27:08 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205669, encodeId=cb73120566925, content=内容好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dae4838671, createdName=1441fef2m15暂无昵称, createdTime=Thu Mar 24 20:49:03 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204484, encodeId=5fc412044842f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/15/f4a39912ff6c27452e6ae02a2e312a5f.jpg, createdBy=6d8d1870826, createdName=果果love, createdTime=Sun Mar 20 23:07:38 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-03-30 洁巴子

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1213119, encodeId=af6e12131190c, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ea1461919, createdName=yangcheng_666139, createdTime=Thu Apr 21 12:05:53 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207126, encodeId=8b26120e1266a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:42:23 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206634, encodeId=11bb120663434, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17b55467916, createdName=ms7000001906418137, createdTime=Mon Mar 28 15:27:08 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205669, encodeId=cb73120566925, content=内容好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dae4838671, createdName=1441fef2m15暂无昵称, createdTime=Thu Mar 24 20:49:03 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204484, encodeId=5fc412044842f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/15/f4a39912ff6c27452e6ae02a2e312a5f.jpg, createdBy=6d8d1870826, createdName=果果love, createdTime=Sun Mar 20 23:07:38 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-03-28 ms7000001906418137

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1213119, encodeId=af6e12131190c, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ea1461919, createdName=yangcheng_666139, createdTime=Thu Apr 21 12:05:53 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207126, encodeId=8b26120e1266a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:42:23 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206634, encodeId=11bb120663434, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17b55467916, createdName=ms7000001906418137, createdTime=Mon Mar 28 15:27:08 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205669, encodeId=cb73120566925, content=内容好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dae4838671, createdName=1441fef2m15暂无昵称, createdTime=Thu Mar 24 20:49:03 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204484, encodeId=5fc412044842f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/15/f4a39912ff6c27452e6ae02a2e312a5f.jpg, createdBy=6d8d1870826, createdName=果果love, createdTime=Sun Mar 20 23:07:38 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-03-24 1441fef2m15暂无昵称

    内容好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1213119, encodeId=af6e12131190c, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ea1461919, createdName=yangcheng_666139, createdTime=Thu Apr 21 12:05:53 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207126, encodeId=8b26120e1266a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:42:23 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206634, encodeId=11bb120663434, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17b55467916, createdName=ms7000001906418137, createdTime=Mon Mar 28 15:27:08 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205669, encodeId=cb73120566925, content=内容好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dae4838671, createdName=1441fef2m15暂无昵称, createdTime=Thu Mar 24 20:49:03 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204484, encodeId=5fc412044842f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/15/f4a39912ff6c27452e6ae02a2e312a5f.jpg, createdBy=6d8d1870826, createdName=果果love, createdTime=Sun Mar 20 23:07:38 CST 2022, time=2022-03-20, status=1, ipAttribution=)]
    2022-03-20 果果love

    学习

    0

拓展阅读

2017 SCCM/ASPEN指南:儿科危重患者营养支持治疗的评估和规定

美国重症医学会(SCCM,Society of Critical Care Medicine) · 2017-07-10

中国重症儿童评估和营养支持治疗指南(英文版)

中国儿科相关医学专家组(统称) · 2018-08-28

中国呼吸危重症患者营养支持治疗专家共识

中国医师协会呼吸医师分会 · 2020-03-03

新型冠状病毒感染患者营养支持治疗专家建议(2023)

北京市临床营养治疗质量控制与改进中心 · 2023-01-31

营养不良肿瘤患者营养支持治疗临床建议路径

中国科技大学附属第一医院西区(安徽省肿瘤医院) · 2023-01-13

法国专家共识:胰腺癌的营养支持

法国专家小组(统称) · 2023-06-24